Argyle Capital Management LLC Sells 5,085 Shares of CVS Health Co. (NYSE:CVS)

Argyle Capital Management LLC reduced its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 14.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,317 shares of the pharmacy operator's stock after selling 5,085 shares during the quarter. Argyle Capital Management LLC's holdings in CVS Health were worth $1,316,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of CVS. State Street Corp increased its position in shares of CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock valued at $3,554,475,000 after buying an additional 1,989,066 shares during the period. Geode Capital Management LLC grew its stake in CVS Health by 1.8% during the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock valued at $1,651,997,000 after acquiring an additional 461,569 shares in the last quarter. Pzena Investment Management LLC increased its holdings in CVS Health by 1.5% during the 3rd quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock worth $825,948,000 after acquiring an additional 198,920 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in CVS Health by 2.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock worth $767,681,000 after purchasing an additional 304,386 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC boosted its holdings in CVS Health by 34.8% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after purchasing an additional 3,071,613 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Activity

In other CVS Health news, Director Michael F. Mahoney acquired 30,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.24% of the stock is currently owned by company insiders.

CVS Health Trading Down 1.4 %

CVS Health stock traded down $0.90 during trading hours on Monday, reaching $64.82. The company had a trading volume of 7,067,486 shares, compared to its average volume of 12,413,437. The firm has a market cap of $81.72 billion, a price-to-earnings ratio of 17.71, a P/E/G ratio of 0.98 and a beta of 0.61. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The company has a 50-day moving average price of $54.33 and a 200 day moving average price of $56.47.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.10%. The ex-dividend date was Thursday, January 23rd. CVS Health's payout ratio is currently 72.68%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CVS. Argus set a $77.00 price objective on CVS Health in a research report on Tuesday, February 18th. UBS Group dropped their price target on CVS Health from $62.00 to $59.00 and set a "neutral" rating for the company in a research report on Tuesday, February 11th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective on the stock in a research report on Tuesday, December 3rd. Leerink Partnrs upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $69.83.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.